Abstract
This chapter provides an overview of how generic topical ophthalmic drug products are approved in the USA. Standards for approval of generic ophthalmic drug products and the role of the Office of Generic Drugs in review of generic ophthalmic drug products are explained. Equivalence evaluation of solution and non-solution topical ophthalmic dosage forms is described, and future research needed to advance equivalence standards are presented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
